Redcliffe Labs expands national footprint with strategic entry into Imphal

Redcliffe Labs, one of India's fastest-growing omnichannel diagnostic service providers, has announced the launch of its first state-of-the-art diagnostic laboratory in Imphal, marking the company's entry into Manipur and further strengthening its commitment to expanding quality healthcare infrastructure across underserved regions of the country. 

With this expansion, Redcliffe Labs becomes one of the first three national diagnostic brands to establish a laboratory footprint in the state, bringing reliable, affordable, and high-quality diagnostic services closer to communities across Manipur.

Located at RIMS Road, Lalambung Makhong, Thangmeiband, the new facility aims to improve access to advanced diagnostics and reduce reliance on sending samples outside the region for testing.

While healthcare infrastructure continues to evolve across the country, access to advanced diagnostic services remains a challenge in several regions, particularly in remote and geographically complex terrains. By establishing a presence in Imphal, Redcliffe Labs aims to strengthen diagnostic access in the region. Every test comes with 4X value benefits, including doctor-verified Smart Reports, expert consultation, personalized diet consultation, and 24x7 AI assistance, enabling individuals to make more informed health decisions with actionable insights along with a digital-first healthcare ecosystem.

The state-of-the-art laboratory will offer a comprehensive range of pathology services across Biochemistry, Hematology, Immunoassays, Clinical Pathology, Serology, Hormone, and Microbiology testing, including automated cultures. Patients can conveniently access these services through both laboratory walk-ins and home sample collection, ensuring greater comfort and flexibility, especially for elderly individuals, patients with mobility constraints, and working professionals. Beyond pathology services, patients will also have access to a wider range of diagnostic services through Redcliffe Labs' collaboration with Padma Diagnostic Center. These include X-Ray, Ultrasound, Portable ECG with tele-reporting, EEG, Spirometry, 24-hour, 48-hour and 72-hour Holter ECG monitoring, and DEXA Scan services.